Amount Raised
$200 Million
Round Type
Post-IPO Equity
WayneBiotechnologyInvestors
Description
On February 25, 2026, Palvella Therapeutics, Inc. completed a significant funding round by entering into an underwriting agreement for the sale of its common stock. The company agreed to issue 1,600,000 shares at a public price of $125.00 per share. This funding will support the company's continued development of its innovative therapies
Quick answer
Palvella Therapeutics raised $200 Million in a Post-IPO Equity round, dated February 26, 2026. Investors: Stifel, Nicolaus & Company, Incorporated, Cantor Fitzgerald & Co. and TD Securities (USA) LLC. Palvella Therapeutics is based in Wayne, Pennsylvania, United States.
- How much did Palvella Therapeutics raise?
- Palvella Therapeutics raised $200 Million in a Post-IPO Equity round on February 26, 2026.
- Who invested in Palvella Therapeutics?
- Stifel, Nicolaus & Company, Incorporated, Cantor Fitzgerald & Co. and TD Securities (USA) LLC are named as investors in this round.
- What does Palvella Therapeutics do?
- Palvella Therapeutics (NASDAQ: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which..
- Where is Palvella Therapeutics based and how big is it?
- Palvella Therapeutics is based in Wayne, Pennsylvania, United States. Fundz records about 30 employees.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Palvella Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Adela raised $5M on April 10, 2026.
- DeepCyte raised $1.5M (Seed) on April 9, 2026.
- ReAlta Life Sciences raised $40M (Funding Round) on April 8, 2026.
- Sidewinder Therapeutics raised $137M (Series B) on April 8, 2026.
- Life Biosciences raised $80M (Series D) on April 8, 2026.
- PanGIA Biotech raised $1.6M (Seed) on April 8, 2026.
Who to call at Palvella Therapeutics, and when
A new round usually means Palvella Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Palvella Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Palvella Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Palvella Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Palvella Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Palvella Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.